期刊文献+

PEG-b-PLL的合成及其自组装纳米基因载体的研究 被引量:1

The studies on PEG-b-PLL copolymer synthesis and self-assemble nano-gene vector
下载PDF
导出
摘要 目的合成两嵌段聚乙二醇-b-聚赖氨酸共聚物(PEG-b-PLL),并评价PEG-b-PLL载基因纳米复合物。方法以端氨基PEG引发Lys(z)-NCA,首先得到两嵌段共聚物PEG-b-PZLL,然后酸解去除苄氧羰基保护基团,得到了两嵌段共聚物PEG-b-PLL。通过正负电荷吸附作用自组装形成PEG-b-PLL载基因纳米复合物,考察其性质。结果制备的PEG-b-PLL载基因纳米复合物外观圆整,呈类球形,大小均匀,平均粒径为(150.3±5.5)nm,其Zeta电位为(-15.82±2.34)mV。该复合物在血浆中稳定,具有一定的抗核酸酶降解能力,且能成功的转染HepG2细胞。结论该复合物是一种制备工艺简单,性能良好,极富潜力的非病毒基因载体。 Purpose To synthesize block copolymer Poly(ethylene glycol)-block-Poly(L-lysine)(PEG-b-PLL),to prepare the PEG-b-PLL and pDNA self-assemble nano-complex and to investigate the potential of the self-assemble nano-complex as a novel gene delivery carrier.Methods The block copolymers PEG-b-PZLL were synthesized by the ring-opening polymerization of Lys(z)-NCA onto amine-terminated PEG,and then by acidolysis to remove benzyloxycarbonyl to obtain PEG-b-PLL.The PEG-b-PLL and pDNA self-assemble into nano-complex through electrostatic interactions between the negative phosphates along the pDNA backbone and positive charges displayed on PLL.The properties were evaluated.Results The obtained pDNA loaded PEG-b-PLL nano-complexes were approximately spherical in shape with average particle size of(150.3±5.5)nm and Zeta potentials of(-15.82±2.34)mv.The nano-complex could protect pDNA from plasma and nuclease degradation in vitro.It showed a low cytotoxicity to HepG2 cells and the results of the gene transfection experiment in vitro suggested that the self-assemble nano-complex could transfer the loaded gene into HepG2 cells,and the gene could express well inside the cells.Conclusion pDNA loaded PEG-b-PLL self-assemble nano-complex could be prepared easily with excellent characteristics and would be a promising non-viral gene vectors.
出处 《中国生化药物杂志》 CAS CSCD 北大核心 2010年第5期302-305,309,共5页 Chinese Journal of Biochemical Pharmaceutics
基金 山东省自然科学基金(ZR2009CM011) 教育部新世纪优秀人才支持计划(NCET-08-0334)
关键词 基因治疗 PEG-b-PLL 纳米复合物 非病毒基因载体 gene therapy PEG-b-PLL nano-complex non-viral gene vector
  • 相关文献

参考文献11

  • 1秦志强,罗赛群,胡维新.非病毒基因转运系统的研究进展[J].国际病理科学与临床杂志,2007,27(2):141-144. 被引量:2
  • 2El-Aneed A.An overview of current delivery systems in cancer gene therapy[J].J Controlled Release,2004,94(1):1-14.
  • 3Wattendorf U,Merkle H P.PEGylation as a tool for the biomedical engineering of surface modified microparticles[J].J Pharm Sci,2008,97(11):4655-4669.
  • 4Gunnarsson A,J(O)nsson P,Marie R,et al.Single-molecule detection and mismatch discrimination of unlabeled DNA targets[J].Nano Lett,2008,8(1):183-188.
  • 5Zhang L,Gu F X,Chan J M,et al.Nanoparticles in medicine:therapeutic applications and developments[J].Clin Pharmacol Ther,2008,83(5):761-769.
  • 6Gao Y,Gu W,Chen L,et al.A multifunetional nano device as nonviral vector for gene delivery:In titro characteristics and transfection[J].J Controlled Release,2007,118(3):381-388.
  • 7邹伟伟,张娜.纳米粒沉淀法制备阳离子载基因PLA-PEG纳米粒[J].中国生化药物杂志,2009,30(1):1-5. 被引量:5
  • 8李洪英,邹伟伟,刘春喜,张娜.阳离子PLGA载基因纳米粒的初步研究[J].中国生化药物杂志,2009,30(2):78-81. 被引量:4
  • 9Kwok K Y,Park Y,Yang Y,et al.In vivo gene transfer using sulfhydryl cross-linked PEG-peptide/glycopeptide DNA co-condensates[J].J Pharm Sci,2003,92:1174-1185.
  • 10Kwok K Y,McKenzie D L,Evers D L,et al.Formulation of highly soluble poly(ethylene glycol)-peptide DNA condensates[J].J Pharm Sci,1999,88:996-1003.

二级参考文献55

  • 1杨菁,宋存先,李拥军,管珩,李大勇.纳米粒子作为基因载体在不同动物模型上的基因转染效果[J].中国医学科学院学报,2006,28(4):475-480. 被引量:2
  • 2Vasir J K, Labhasetwar V. Biodegradable nanoparticles for cytosolic delivery of therapeutics[J]. Adv Drug Deliv Rev,2007,59(8) :718-728.
  • 3Mundargi R C, Babu V R, Rangaswamy V, et al. Nano/micro technologies for delivering macromolecular therapeutics using poly ( D, L-lactide-co-glycolide) and its derivatives [ J]. J Controlled Release, 2008, 125(3) : 193-209.
  • 4Eley J G, Mathew P. Preparation and release characteristics of insulin and insulin-like growth factor-one from polymer nanoparticles[J]. J Microencapsul, 2007,24( 3 ) : 225-234-.
  • 5Abeylath S C, Turos E. Glycosylated polyacrylate nanoparticles by emulsion polymerization [ J ]. Carbohydr Polym, 2007,70 ( 1 ) : 32-37.
  • 6Legrand P, Lesieur S, Bochot A, et al. Influence of polymer behaviour in organic solution on the production of polylactide nanoparticles by nano- precipitation[J]. Int J Pharm,2007,344(1-2) :33-43.
  • 7McCarron P A, Donnelly R F, Marouf W. Celecoxib-loaded poly( D, L- lactide-co-glycolide) nanoparticles prepared using a novel and control- lable combination of diffusion and emulsification steps as part of the salting-out procedure[J] .J Microencapsul,2006,23(5) :480-498.
  • 8Quintanar-Guerrero D, All,mann E, Fessl H, et al. Preparation techniques and mechanisms of formation of biodegradable nanopartieles from preformed polymers [ J ] . Drug Dev Ind Pharm, 1998,24 (12) : 1113- 1128.
  • 9Bilati U, Allemann E, Doelker E. Development of a nanoprecipitation method intended for the entrapment of hydrophilic drugs into nanoparticles [ J ]. Eur J Pharm Sci, 2005,24( 1 ) : 67-75.
  • 10Prabha S, Zhou W Z, Panyam J, et al. Size-dependency of nanoparticlemediated gene transfection : studies with fractionated nanopartieles [ J ] .Int J Pharm,2002,244(1-2):105-115.

共引文献8

同被引文献19

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部